Skip to main content
. 2024 Jun 19;16(6):3794–3804. doi: 10.21037/jtd-23-1668

Table 1. Description of cohort of patients in the National Cancer Database with non-small cell lung cancer, who either had no metastatic cancer or isolated brain metastasis.

Characteristics No metastasis Isolated brain metastasis P value
Age (years) 70 [18–90] 66 [18–90] <0.001
Male (versus female) 179,040 (48.4) 12,953 (50.0) <0.001
Caucasian 306,587 (82.8) 20,098 (77.6) <0.001
Insurance status <0.001
   Not insured 4,977 (1.3) 910 (3.5)
   Private insurance 79,273 (21.4) 7,285 (28.1)
   Medicaid 23,270 (6.3) 3,181 (12.3)
   Medicare 250,211 (67.6) 13,602 (52.5)
   Other 8,842 (2.4) 599 (2.3)
   Unknown 3,633 (1.0) 330 (1.3)
Academic program 195,274 (52.7) 14,231 (54.9) <0.001
Histology <0.001
   Adenocarcinoma 190,068 (51.3) 18,494 (71.4)
   Squamous carcinoma 128,569 (34.7) 3,796 (14.7)
   Other 51,569 (13.9) 3,617 (14.0)
Grade <0.001
   Well-differentiated 29,319 (7.9) 356 (1.4)
   Moderately differentiated 72,926 (19.7) 2,246 (8.7)
   Poorly differentiated 67,908 (18.3) 6,443 (24.9)
   Undifferentiated 1,539 (0.4) 170 (0.7)
   Cannot be assessed/unknown 198,514 (53.6) 16,692 (64.4)
Clinical T-stage <0.001
   cT1 113,464 (30.6) 3,157 (12.2)
   cT2 54,726 (14.8) 4,887 (18.9)
   cT3 27,523 (7.4) 2,919 (11.3)
   cT4 22,307 (6.0) 2,764 (10.7)
   Missing 152,186 (41.1) 12,180 (47.0)
Clinical N-stage <0.001
   cN0 157,785 (42.6) 4,664 (18.0)
   cN1 15,422 (4.2) 1,764 (6.8)
   cN2 39,400 (10.6) 5,853 (22.6)
   cN3 12,809 (3.5) 2,132 (8.2)
   Missing 144,790 (39.1) 11,494 (44.4)
Charlson/Deyo comorbidity score <0.001
   0 203,991(55.1) 16,632 (64.2)
   1 91,024 (24.6) 5,275 (20.4)
   2 40,938 (11.1) 2,212 (8.5)
   ≥3 34,253 (9.3) 1,788 (6.9)

Data shown includes median and interquartile range for continuous variables or n (%) for categorical variables. Differences calculated using chi-square or rank sum test.